VIVUS (VVUS) Short Interest Ratio & Short Volume

Short interest is the volume of VIVUS shares that have been sold short but have not yet been closed out or covered. As of June 30th, investors have sold 3,010,000 shares of VVUS short. Learn More on VIVUS's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VVUS shares currently have a short interest ratio of 3.0. Learn More on VIVUS's short interest ratio.

VIVUS saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 3,010,000 shares, an increase of 489.4% from the previous total of 510,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the sector of "medical" compare to VIVUS: Cumberland Pharmaceuticals Inc. (0.21%), eFFECTOR Therapeutics, Inc. (10.72%), Chemomab Therapeutics Ltd. (1.87%), Trevena, Inc. (0.63%), Pasithea Therapeutics Corp. (1.17%), Tenax Therapeutics, Inc. (2.62%), Pulmatrix, Inc. (0.07%), Lixte Biotechnology Holdings, Inc. (0.97%), Sunshine Biopharma, Inc. (0.77%), Clever Leaves Holdings Inc. (1.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Match Group, Inc. ($4.49 billion), Wayfair Inc. ($3.21 billion), Tesla, Inc. ($3.01 billion), Morgan Stanley ($2.93 billion), The Charles Schwab Co. ($2.55 billion), Aon plc ($2.52 billion), The Clorox Company ($2.41 billion), Snap Inc. ($2.25 billion), Carnival Co. & plc ($2.06 billion), and Simon Property Group, Inc. ($1.88 billion). View all of the most shorted stocks.

Short selling VVUS is an investing strategy that aims to generate trading profit from VIVUS as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for VIVUS occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of VVUS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VVUS, twice per month. The most recent reporting period available is June, 30 2020.